Recombinant baculovirus occlusion bodies in vaccines and biologi

Chemistry: molecular biology and microbiology – Vector – per se

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 68, 435 91, 4351723, 435235, 435243, 536 27, 935 32, 935 57, 935 70, 530350, 530820, 530826, C12N 700, C12N 1500, C12N 100, C12P 2100

Patent

active

048700231

ABSTRACT:
The present invention is directed to recombinant baculoviruses which encode fusion polyhedrin proteins capable of forming occlusion bodies containing foreign peptides. The recombinant baculoviruses of the invention are formed by insertion into or replacement of regions of the polyhedrin gene that are not essential for occlusion body formation, with foreign DNA fragments by recombinant DNA techniques. The recombinant occlusion bodies produced in accordance with the present invention have uses in vaccine formulations, immunoassays, immobilized enzyme reactions, as biological insecticides, and as expression vectors.

REFERENCES:
patent: 4722849 (1988-02-01), Valenzuela et al.
patent: 4745051 (1988-05-01), Smith et al.
Carstens et al. (1987) J. Gen. Vir., 68: 901-5.
Smith et al. (1981), J. Virology, 39: 125-37.
Kuroda et al. (1986), EMBO J., 5: 1359-65.
Harrap, 1972, Virology, 50: 124-132.
Engstrom, 1974, Biochem. Exp. Biol., 11: 7.
Epstein et al., 1977, Biochem. J., 167: 321-332.
Rohrmann et al., 1977, Biochemistry, 16: 1634.
Maruniak et al., 1978, J. Invert. Pathol., 32: 196-201.
Tinsley, T. and Harrap, K., 1978, "Comprehensive Virology", vol. 12, pp. 1-101, H. Fraenkel-Conrat and R. Wagner, Eds., Plenum Press, NY.
Scharnhorst, D. and Weaver, R., 1980, Virology, 102: 468-472.
McIntosh et al., 1981, J. Invert. Pathol., 37: 258-264.
Tweeten et al., 1981, Microbiological Rev., 45: 379-408.
Duncan et al., 1983, J. Gen. Virology, 64: 1531-1542.
Tjia et al., 1979, Virology, 99: 399-409.
Rohrmann et al., 1981, J. Mol. Evol., 17: 329-333.
Vlak et al., 1981, J. Virology, 40: 1531-1542.
Adang et al., 1982, J. Virology, 44: 782-793.
Smith, G. and Summers, M., 1982, Virology, 123: 393-406.
Vlak et al., 1982, Virology, 123: 222-228.
Erlandson et al., 1983, Virology, 126: 398-402.
Smith et al., 1983, J. Virology, 45: 215-225.
Smith et al., 1983, J. Virology, 46: 584-593.
Knell & Summers, 1984, J. Gen. Virology, 65: 445-450.
Heng et al., 1985, Scientia Sinica, pp. 1051-1059.
Leisy et al., 1986, Virology, 153: 280-288.
Miller, L. K., 1981, Genetic Engineering in Plant Sciences, Praeger Publishers, New York, pp. 203-224.
Smith et al., 1983, Mol. Cell. Biol., 3: 2156-2165.
Maeda et al., 1984, Proc. Japan Acad., 60: 423-426.
Pennock et al., 1984, Mol. Cell. Biol., 4: 399-406.
Carbonell et al., 1985, J. Virology, 56: 153-160.
Maeda et al., 1985, Nature, 315: 592-594.
Miyamoto et al., 1985, Mol. Cell. Biol., 5: 2860-2865.
Summers, M. D. and Smith, G., 1985, Genetic Engineering of Baculoviruses, Genetically Altered Viruses and the Environment; Meeting, Cold Spring Harbor, N.Y., Apr. 28-May 1, 1985, pp. 319-331.
Matsura et al., 1986, J. Gen. Virol., 67: 1515-1529.
Possee, 1986, Virus Research, 5: 43-59.
Estes et al., 1987, J. Virology, 61: 1488-1494.
Hu et al., 1987, J. Virology, 61: 3617-3620.
Inumaru et al., 1987, J. Gen. Virol., 68: 1627-1635.
Jeang et al., 1987, J. Virology, 61: 1761-1764.
Matsuura et al., 1987, J. Gen. Virology, 68: 1233-1250.
Rice et al., 1987, J. Virology, 61: 1712-1716.
Luckow et al., 1988, Biotechnology, 6: 47-55.
Hohmann et al., 1983, Virology, 125: 432-444.
Quant et al., 1984, Applied and Environmental Microbiology, 48: 732`736.
Huang et al., 1985, Virology, 143: 380-391.
Steeves et al., 1974, J. Virology, 14: 187-189.
Dalyrample et al., 1981, in "The Replication of Negative Strand Viruses", ed. Bishop, D. and Compans., R., Elseveir North Holland Publishers, N.Y., pp. 167-172.
Massey et al., 1981, Virology, 115: 20-32.
Gonzalez-Scarano et al., 1982, Virology, 120: 42-53.
Mathews et al., 1982, J. Immunol., 129: 2763-2767.
Matsuno et al., 1983, Infection and Immunity, 39: 155-158.
Warren, 1985, "Vaccines", 85, Lerner, R. et al., Eds., Cold Spring Harbor Laboratory, New York, pp. 373-376.
Granoff et al., 1986, J. Infect. Dis., 153: 448-461.
European Patent Application #0 127 839, Smith et al., Application No. 84105841.5, published Dec. 12, 1984.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant baculovirus occlusion bodies in vaccines and biologi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant baculovirus occlusion bodies in vaccines and biologi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant baculovirus occlusion bodies in vaccines and biologi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-187407

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.